Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trialZiad Hijazi, Lars Wallentin, Gianpaolo Reboldi et al.|IrInSubria (University of Insubria)|2019Cited by 22
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) studyPaolo Verdecchia, Giuseppe Di Pasquale, Gianpaolo Reboldi et al.|EP Europace|2017Cited by 19